Big Move For Apimeds Pharmaceuticals US, Inc

Fri, Nov 28, 2025 at 07:43 PM

Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT) rocketted at $2.9, representing a gain of 32.4%. The stock got featured on our News Catalysts scanner on Mon, Nov 10, 2025 at 10:40 AM in the 'BIOTECH' category. From Mon, Nov 17, 2025, the stock recorded 25.00% Up Days and 33.33% Green Days

About Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT)

Apimeds Pharmaceuticals US is a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits...

Top 10 Gainers:

SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 250.8%
Twin Vee Powercats Co. (VEEE:NASDAQ), 45.51%
Pasithea Therapeutics Corp. (KTTA:NASDAQ), 38.68%
Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 35.62%
Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT), 32.42%
Nature Wood Group Limited (NWGL:NASDAQ), 30.56%
OneMedNet Corporation (ONMD:NASDAQ), 30.28%
HeartBeam, Inc. (BEAT:NASDAQ), 27.55%
Next Technology Holding Inc. (NXTT:NASDAQ), 24.89%
Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 23.91%